The recent adverse findings in Jon Jones’ USADA drug test results popped up much earlier than December, according to UFC executive Jeff Novitzky.
Novitzky, the UFC’s vice president of athlete health and performance, appeared Thursday on The Joe Rogan Experience to explain Jones’ recent drug-testing situation and the UFC’s decision to uproot UFC 232 from Las Vegas to Los Angeles on less than a week’s notice. Novitzky revealed that Jones first tested positive for trace amounts of a longterm metabolite of oral turinabol in an Aug. 29 drug screening conducted by USADA.